Oramed Pharmaceuticals | 10-K: FY2024 Annual Report
Congressional Trading Report: Rep. Brad Knott Sold Over $15K In Oramed Pharmaceuticals Stock
Congress Trade: Representative Brad Knott Just Disclosed New Stock Trades
Oramed Pharmaceuticals And 2 Other US Penny Stocks To Watch
Oramed (ORMP) Stock Skyrockets Amid JV Development Plans
Oramed Pharmaceuticals Shares Are Trading Higher After the Company Announced a Definitive Agreement to Spin off Its Protein Oral Delivery Technology Into a Joint Venture With Hefei Tianhui Biotech.
Oramed Announces Spinoff of Protein Drug Technology
Express News | Oramed Pharmaceuticals Inc: Oramed Shareholders to Receive Right to a Direct Stake in Oratech, Expected to Go Public on Nasdaq
Express News | Oramed Pharmaceuticals Inc - New Phase 3 Trial in U.S. Expected to Begin This Quarter
Express News | Oramed Pharmaceuticals Inc - Announces Joint Venture With Htit to Form Oratech
Oramed Announces Transformative Joint Venture to Accelerate Development and Commercialization of Oral Insulin
Express News | Oramed Pharmaceuticals Inc - on Dec 13, Received $13.2 Mln Payment From Scilex, Pursuant to Terms of Tranche a Note
Scilex Announces Voluntary $13.2M Early Payment On Oramed Note, Full Retirement Set For March 2025
Oramed Pharmaceuticals | 10-Q: Q3 2024 Earnings Report
Oramed Pharmaceuticals Reinforces Scilex Financial Ties
Express News | Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Press Release: Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt
Sector Update: Health Care Stocks Decline Monday Afternoon
Scilex Holding to Pay $2 Million to Oramed Pharmaceuticals in Loan Accord
Express News | Oramed Pharmaceuticals Inc: Scilex to Pay $2 Mln to Co. Under Letter Agreement